FARP1

Across TCGA pan-cancer cohorts, FARP1 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated FARP1 data layer compared with 27 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher FARP1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated FARP1 expression acts as an unfavorable survival marker, although some lineages such as CCRCC show a favorable association.

PDAC, CCRCC, and HNSC are the cancer types where FARP1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	DFS	Median	II,III,IV	0.668	0.882	.001	39	view →
CCRCC	DFS	Tertile	III,IV	0.837	0.307	.002	32	view →
HNSC	DFS	Median	All	0.361	0.860	.022	13	view →
LSCC	OS	Quartile	All	0.603	1.000	.018	11	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

FARP1–PDAC (DFS)

Open the PDAC breakdown →